Breaking News, Collaborations & Alliances

GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact

Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.

GenScript ProBio, a global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines, entered a strategic partnership for the manufacturing of GMP-grade plasmid DNA (pDNA) for its mRNA COVID-19 vaccine candidate, RVM-V001, along with collaboration for future therapeutic pipelines. GenScript ProBio will provide GMP plasmid manufacturing ser...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters